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Sir,
Isolates from a collection of 177 antibiotic-resistant Acinetobacter
recovered at Westmead Hospital, Sydney over the period 1995–
20021 were further characterized. The relationships among these
isolates had previously been examined by PFGE of ApaI-digested
DNA, determination of MICs of several antibiotics and PCR screen-
ing to determine whether the blaOXA-23 gene or class 1 integrons
were present.1 Eight PFGE pulsotypes were detected. The majority
of isolates were A. baumannii but five isolates (PFGE pulsotypes III
and IV) were not, and these were not examined here. One or two
isolates from each year for each remaining pulsotype were tested
using triplex PCRs targeting the oxa-Ab, csuE and ompA genes,2 to
determine whether they belong to global clone 1 (GC1) or global
clone 2 (GC2). Pulsotype I isolates were GC1 and isolates from pul-
sotypes VI, VII and VIII, which first appeared in 1999, were GC2.
The 54 GC2 isolates were the only isolates resistant to imipenem
and carried the blaOXA-23 gene.
1 Types II (n¼64) and V (n¼2) did
not belong to either global clone. This is consistent with a previous
report using a smaller number of isolates.3
Pulsotype I included 52 isolates and was present in the hospital
intensive care unit from 1995 to 1999, with a single isolate recov-
ered in 2000. Isolates in this group are among the earliest multiply
antibiotic-resistant A. baumannii reported in Australia. They were
gentamicin resistant and carried the aacC1-orfP-orfP-orfQ-aadA1
cassette array in a class 1 integron.1 They were also resistant to ci-
profloxacin but susceptible to third-generation cephalosporins and
carbapenems.1 Consistent with the GC1 designation, WM98, one of
two representatives examined previously, was found here to
belong to sequence type ST109 [Oxford multilocus sequence
typing (MLST) scheme]. Ten representative isolates, including
WM98, covering each of the years 1995–99, were examined in
more detail, and, in contrast to the previous report,1 WM98 and
other members of this group did not include a copy of ISAba1.
The resistance profile was expanded using disc diffusion, and
the resistance genes present were determined by PCR.4 The
comM gene was interrupted, and they were found to also carry
the sul1 sulphonamide resistance gene, the tet(A) tetracycline
resistance determinant and transposon Tn6020 carrying the
aphA1b kanamycin and neomycin resistance gene. The catA1
and blaTEM genes were also present. PCR mapping
5 of WM98
together with sequencing of all IS26 junctions revealed the pre-
sence of a genomic resistance island very closely resembling
AbaR3 in AB00576 (GenBank accession number CP001182).
We had noticed that AbaR3 contained a deletion of 108 bp in the
5′-conserved segment (5′-CS) of the class 1 integron, and that this
deletion was not present in AbaR5,4 which now has been completely
sequenced (GenBank accession number FJ172370), or in AbaR1 in
AYE (GenBank accession number CU459141) or in AbaR2 in the
GC2 isolate ACICU (GenBank accession number CP000863). The
location of this deletion is indicated in Figure 1(a). It removes the
last 52 bp of the intI1 gene, and the loss of conserved amino acids
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in the 16 amino acids replaced at the C-terminus of IntI17 is likely to
inactivate it. The deletion appears to have arisen via a rare recombi-
nation event or a replication slippage event involving a very short,
8 bp duplication present in the 5′-CS (Figure 1b). Whether the dele-
tion was present in the AbaR of the WM98 group was examined
using PCR with primers RH882 (5′-GATGCGTGCACTACGCAAAG-3′)
and intI1-RV (5′-GGGCATGGTGGCTGAAGGACC-3′), which generate
an amplicon of 1222 bp when the 5′-CS is complete and 1114 bp
when the deletion is present and fragments of 659+563 or
659+455 bp after digestion with BamHI. The 5′-CS is intact in
WM98 and related isolates, and this was confirmed by sequencing
the PCR amplicon from WM98. This configuration with a complete
5′-CS is likely to pre-date the lineage that includes the deletion,
making it the most likely ancestor of AbaR3 and the various AbaR
configurations that have arisen subsequently. Therefore, we
propose that the AbaR island of WM98 should be named AbaR0.
The complete sequence of AbaR0 was assembled8 from the whole
genome sequence of WM98 determined using Illumina HiSeq, gen-
erating 100 bp paired-end reads, and has been deposited in the
GenBank DNA database under accession number KF483599.
Asthe deletion in intI1 results from a rare event, it has the poten-
tial to assist in tracking different AbaR (i.e. islands in comM with a
Tn6019 backbone) and hence GC1 lineages. Therefore its presence
in other Australian GC1 isolates was examined. Isolates with an
intact 5′-CS and ones with the deletion were both present among
these strains. In AbaR21 in the reference GC1 strain RUH875/
A297 from 1984,9 as well as in AbaR6 and AbaR7 found in isolates
from 2006 and 2005,5 the 5′-CS is intact. In contrast, AbaR8, found
in isolates from 2008,10 includes the deletion. Three sporadic
isolates from different Australian cities, A85, RBH3 and 6772166,
recovered in 2002 or 2003 and described recently as carrying
AbaR3,11 included the deletion. This deletion, which can be
simply detected by PCR, will serve as an additional marker for
diverged lineages within the GC1 clone.
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Figure 1. (a) Structure of the part of AbaR islands containing the integron
and adjacent Tn6020. The positions of PCR primers used to detect the
deletion are indicated below, and the vertical arrow indicates the location
of the deletion in the 5′-CS. (b) Alignment of the 3208 and AB0057
sequences in the vicinity of the deletion. Identical bases are indicated by
vertical lines and bases that occur twice in 3208 are white on black.
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